I. I.Ioit* |Klfi J,") S q,4.,4j I T,-)Al- >.1 (. .'Jb l i'1.JO,I:?,4
| Page | |
|---|---|
| Reference and administrative details of the company, its Trustees and advisers | 1 |
| Chairman's statement | 2 |
| Trustees' report | 3 −23 |
| Trustees' responsibilities statement | 24 |
| Independent examiner's report | 25 |
| Statement of financial activities | 26 |
| Balance sheet | 27 |
| Statement of cash flows | 28 |
| Notes to the financial statements | 29 −39 |
| The following pages do not form part of the statutory financial statements: | |
| Appendix I −Glossary of terms |
| atistics below are consistent with p | revious years |
|---|---|
| British | 85.98% |
| Irish | 0.36% |
| Any other White background | 1.61% |
| White and Black Caribbean | 0.05% |
| White and Black African | 0.10% |
| Any other mixed background | 0.67% |
| Indian | 0.26% |
| Pakistani | 0.05% |
| Any other Asian background | 0.21% |
| Caribbean | 0.16% |
| Any other Black background | 0.57% |
| Any other ethnic group Not known |
0.88% 9.09% |
| Problem Descriptor | Count | |
|---|---|---|
| 01.01.2020 −31.12.2020 | ||
| Depressive episode | 499 | 25.92% |
| Generalized anxiety disorder | 377 | 19.57% |
| Recurrent depressive disorder | 101 | 5.24% |
| Post−traumatic stress disorder | 65 | 3.37% |
| Mixed anxiety and depressive disorder | 39 | 2.02% |
| Social phobias | 30 | 1.56% |
| Obsessive−compulsive disorder | 23 | 1.19% |
| Mental disorder, not otherwise specified | 22 | 1.14% |
| Disappearance and death of family member | 19 | 0.99% |
| Specific (isolated) phobias | 14 | 0.73% |
| Panic disorder [episodic paroxysmal anxiety] | 13 | 0.67% |
| Agoraphobia | 9 | 0.47% |
| Bipolar affective disorder | 4 | 0.21% |
| Eating disorders | 1 | 0.05% |
| Stress related | 56 | 2.91% |
| Somatoform related | 24 | 1.25% |
| All Relationship related issues | 20 | 1.04% |
| Other | 1 | 0.05% |
| No code provided | 609 | 31.62% |
| Unrestricted | Total | Total | ||
|---|---|---|---|---|
| funds | funds | funds | ||
| 2020 | 2020 | 2019 | ||
| Note | £ | £ | £ | |
| Income from: | ||||
| Charitable activities | 2 | 822,763 | 822,763 | 647,197 |
| Investments | 3 | 1,906 | 1,906 | 2,586 |
| Other income | 4 | 685 | ||
| Total income | 824,669 | 824,669 | 650,468 | |
| Expenditure on: | ||||
| Charitable activities | 5 | 721,962 | 721,962 | 609,677 |
| Total expenditure | 721,962 | 721,962 | 609,677 | |
| Net movement in funds | 102,707 | 102,707 | 40,791 | |
| Reconciliation of funds: | ||||
| Total funds brought forward | 181,506 | 181,506 | 140,715 | |
| Net movement in funds | 102,707 | 102,707 | 40,791 | |
| Total funds carried forward | 284,213 | 284,213 | 181,506 |
| 2020 | 2019 | ||||
|---|---|---|---|---|---|
| Note | £ | £ | |||
| Fixed assets | |||||
| Tangible assets | 11 | 8,434 | 2,261 | ||
| 8,434 | 2,261 | ||||
| Current assets | |||||
| Debtors | 12 | 100,714 | 57,098 | ||
| Cash at bank and in hand | 235,883 | 159,157 | |||
| 336,697 | 216,255 | ||||
| Creditors: amounts falling due within one | |||||
| year | 13 | (60,818) | (37,010) | ||
| Net current assets | 275,779 | 179,245 | |||
| Total assets less current liabilities | 284,213 | 181,506 | |||
| Total net assets | 284,213 | 181,506 | |||
| Charity funds | |||||
| Unrestricted funds | 14 | 284,213 | 181,506 | ||
| Total funds | 284,213 | 181,506 |
| Statement of cash flows for the year ended 31 December 2020 |
||
|---|---|---|
| 2020 | 2019 | |
| £ " |
||
| Cash flows from operating activities | ||
| Net cash used in operating activities | 86,715 | 53,663 |
| Cash flows from investing activities | ||
| Purchase of tangible fixed assets | (9,989) | (594) |
| Net cash used in investing activities | (9,989) | (594) |
| Cash flows from financing activities | ||
| Change in cash and cash equivalents in the year | 76,726 | 53,069 |
| Cash and cash equivalents at the beginning of the year | 159,157 | 106,088 |
| Cash and cash equivalents at the end of the year | 235,883 | 159,157 |
| The notes on pages 29 to 39 form part of these financial statements |
| Unrestricted | Total | Total | ||
|---|---|---|---|---|
| funds | funds | funds | ||
| 2020 | 2020 | 2019 | ||
| Counselling services | 822,763 | 822,763 | 647,197 | |
| Total 2019 | 647,197 | 647,197 | ||
| 3. | Investment income | |||
| Unrestricted | Total | Total | ||
| funds | funds | funds | ||
| 2020 | 2020 | 2019 | ||
| Investment income | 1,906 | 1,906 | 2,586 | |
| Total 2019 | 2,586 | 2,586 | ||
| 4. | Other incoming resources | |||
| Unrestricted | Total | Total | ||
| funds | funds | funds | ||
| 2020 | 2020 | 2019 | ||
| CPD Training and SAR's income | 685 | |||
| Total 2019 | 685 | 685 |
| Unrestricted | Total | Total | |
|---|---|---|---|
| funds | funds | funds | |
| 2020 | 2020 | 2019 | |
| Counselling services | 721,962 | 721,962 | 609,677 |
| Total 2019 | 609,677 | 609,677 |
| Activities | ||||
|---|---|---|---|---|
| undertaken | Support | Total | Total | |
| directly | costs | funds | funds | |
| 2020 | 2020 | 2020 | 2019 | |
| Counselling services | 244,383 | 477,579 | 721,962 | 609,677 |
| Total 2019 | 348,409 | 261,268 | 609,677 |
| Counselling | Total | Total | |
|---|---|---|---|
| services | funds | funds | |
| 2020 | 2020 | 2019 | |
| Counsellor costs | 214,702 | 214,702 | 295,975 |
| Room hire and other operating leases | 29,681 | 29,681 | 52,434 |
| Total 2020 | 244,383 | 244,383 | 348,409 |
| Total 2019 | 348,409 | 348,409 |
| Counselling | Total | Total | |
|---|---|---|---|
| services | funds | funds | |
| 2020 | 2020 | 2019 | |
| Staff costs | 348,356 | 348,356 | 150,749 |
| Depreciation | 3,816 | 3,816 | 722 |
| Insurance | 1,439 | 1,439 | 1,519 |
| Telephone | 4,589 | 4,589 | 3,534 |
| Postage and stationery | 2,328 | 2,328 | 4,289 |
| Advertising | 180 | 180 | 1,402 |
| Other costs | 14,161 | 14,161 | 2,821 |
| Printing | 1925, | 1,925 | 2,223 |
| Travel | 397 | 397 | 2,789 |
| IT expenses | 27,139 | 27,139 | 23,465 |
| Accounting and bookkeeping | 5,482 | 5,482 | 7,787 |
| Professional fees | 504 | 504 | 103 |
| Director of Services management fees | 61,606 | 61,606 | 52,159 |
| Repairs and maintenance | 586 | 586 | 738 |
| Cleaning | 790 | 790 | 2,212 |
| Subscriptions | 816 | 816 | 1,419 |
| Bank charges | 105 | 105 | 205 |
| Governance costs | 3,360 | 3,360 | 3,132 |
| 477,579 | 477,579 | 261,268 | |
| Total 2019 | 261,268 | 261,268 |
| 2020 | 2019 | |
|---|---|---|
| This is stated after charging: | ||
| Depreciation of tangible fixed assets: owned by the charity | 3,816 | 722 |
| 2020 | 2019 | |
|---|---|---|
| £ | £ | |
| Wages and salaries | 319,927 | 140,265 |
| Social security costs | 23,422 | 7,866 |
| Contribution to defined contribution pension schemes | 5,007 | 2,618 |
| 348,356 | 150,749 |
| 2020 | 2019 | |
|---|---|---|
| No. | No. | |
| 14 | 7 |
| Fixtures and | Computer | ||
|---|---|---|---|
| fittings | equipment | Total | |
| £ | £ | £ | |
| Cost or valuation | |||
| At 1 January 2020 | 3,810 | 13,465 | 17,275 |
| Additions | 1,691 | 8,298 | 9,989 |
| At 31 December 2020 | 5,501 | 21,763 | 27,264 |
| Depreciation | |||
| At 1 January 2020 | 2,521 | 12,493 | 15,014 |
| Charge for the year | 1,717 | 2,099 | 3,816 |
| At 31 December 2020 | 4,238 | 14,592 | 18,830 |
| Net book value | |||
| At 31 December 2020 | 1,263 | 7,171 | 8,434 |
| At 31 December 2019 | 1,289 | 972 | 2,261 |
| Debtors | |||
| 2020 | 2019 | ||
| £ | £ | ||
| Due within one year | |||
| Trade debtors | 1,040 | 520 | |
| Other debtors | 653 | 1,586 | |
| Prepayments and accrued income | 99,021 | 54,992 | |
| 100,714 | 57,098 |
| 2020 | 2019 | |
|---|---|---|
| Trade creditors | 21,775 | 22,792 |
| Other taxation and social security | 20,059 | 2,883 |
| Other creditors | 1,912 | 836 |
| Accruals and deferred income | 17,072 | 10,499 |
| 60,818 | 37,010 |
| Statement of funds −current year | ||||
|---|---|---|---|---|
| Balance at | ||||
| Balance at 1 | 31 | |||
| January | December | |||
| 2020 | **Income ** | Expenditure | 2020 | |
| Unrestricted funds | ||||
| General Funds | 181,506 | 816,070 | (713,363) | 284,213 |
| Unallocated amounts | 8,599 | (8,599) | ||
| 181,506 | 824,669 | (721,962) | 284,213 | |
| Statement of funds −prior year | ||||
| Balance at | Balance at | |||
| 1 January | 31 December | |||
| 2019 | Income | Expenditure | 2019 | |
| Unrestricted funds | ||||
| General Funds | 140,715 | 647,103 | (606,312) | 181,506 |
| Summary of funds −current year | ||||
|---|---|---|---|---|
| Balance at | ||||
| Balance at 1 | 31 | |||
| January | December | |||
| 2020 | **Income ** | Expenditure | 2020 | |
| £ | £ | £ | £ | |
| General funds | 181,506 | 824,669 | (721,962) | 284,213 |
| Summary of funds −prior year | ||||
| Balance at | Balance at | |||
| 1 January | 31 December | |||
| 2019 | Income | Expenditure | 2019 | |
| £ | £ | £ | £ | |
| General funds | 140,715 | 647,103 | (606,312) | 181,506 |
| Analysis of net assets between funds −current pe | riod | |
|---|---|---|
| Unrestricted | Total | |
| funds | funds | |
| 2020 | 2020 | |
| £ | £ | |
| Tangible fixed assets | 8,434 | 8,434 |
| Current assets | 336,597 | 336,597 |
| Creditors due within one year | (60,818) | (60,818) |
| Total | 284,213 | 284,213 |
| Analysis of net assets between funds −prior perio | d | |
|---|---|---|
| Unrestricted | Total | |
| funds | funds | |
| 2019 | 2019 | |
| £ | £ | |
| Tangible fixed assets | 2,261 | 2,261 |
| Current assets | 216,255 | 216,255 |
| Creditors due within one year | (37,010) | (37,010) |
| 181,506 | 181,506 |
| 2020 | 2019 | |
|---|---|---|
| £ | £ | |
| Net income for the period (as per Statement of Financial Activities) | 102,707 | 40,791 |
| Adjustments for: | ||
| Depreciation charges | 3,816 | 722 |
| Loss/(profit) on the sale of fixed assets | − | (789) |
| Decrease/(increase) in debtors | (43,616) | 13,268 |
| Increase/(decrease) in creditors | 23,808 | (329) |
| Net cash provided by operating activities | 86,715 | 53,663 |
| 2020 | 2019 | ||
|---|---|---|---|
| £ | £ | ||
| Cash in hand | 235,883 | 159,157 | |
| Total cash and cash equivalents | 235,883 | 159,157 | |
| Analysis of changes in net debt | |||
| At 1 | At 31 | ||
| January | December | ||
| 2020 | Cash flows | 2020 | |
| £ | £ | £ | |
| Cash at bank and in hand | 159,157 | 76,726 | 235,883 |
| 159,157 | 76,726 | 235,883 |
| In the IAPT context, course accreditation with a recognised professional body | |
|---|---|
| indicates that the training programme has undergone a process of scrutiny to | |
| Accreditation | ensurethat its curriculum, teaching materials, staffing, resources, |
| management and governance structures have met the necessary national | |
| curricula requirements as agreed and laid down by the IAPT programme. | |
| ADSM | Anxiety disorder specific measure |
| British Association for Behavioural & Cognitive Psychotherapies | |
| The lead organisation for Cognitive Behavioural Therapy (CBT) in the UK and | |
| Ireland. It promotes, improves and upholds standards of CBT practice, | |
| BABCP | supervision and training. It supports its members to develop professionally |
| and links with the CBT community. It is a professional association operating a | |
| highly−respected voluntary register for our accredited cognitive behavioural | |
| psychotherapists, and help to protect the public by supporting best practice. | |
| British Association for Counselling & Psychotherapy | |
| BACP | It is the professional association for members of the counselling professions in |
| the UK. | |
| Bipolar | Formally called Manic Depression, is a mental health condition which causes |
| Disorder | extreme mood swings, that includes emotional highs and lows |
| Border line personality disorder, also known as, emotionally unstable | |
| BPD | personality disorder (EUPD). A disorder of mood where a person is unable to |
| stabilise emotional regulation and their interactions with others. | |
| Under IAPT requirements, a person is said to be at "caseness" when their | |
| symptom score exceeds theaccepted clinical threshold for the relevant | |
| measure of symptoms. For the PHQ−9, this is a scoreof 10orabove. For the | |
| Caseness | GAD−7, this is a score of 8 or above. Other symptom measures, such as those used to measure the severity of different anxiety disorders, have their own |
| specific thresholds. Some outcome measures (such as the WSAS) do not have | |
| recommended caseness thresholds but provide valuable additional | |
| information about the quality of a treatment response. | |
| Cognitive Behavioural Therapy | |
| This is a type of talking treatment which focuses on how your thoughts, | |
| beliefs and attitudes affect your feelings and behaviour, and teaches | |
| CBT | you coping skills for dealing with different problems. It combines cognitive therapy (examining the things you think) and behaviour |
| therapy (examining the things you do). | |
| CCG | Clinical Commissioning Group |
| COPD | Chronic obstructive pulmonary disease |
| CPD | Continuing professional development |
| CQC | Care Quality Commission |
| DIT | Dynamic Interpersonal Therapy |
| DNA | Did Not Attend |
|---|---|
| EMDR | Eye Movement Desensitisation Reprocessing Therapy |
| GAD−7 | Generalised Anxiety Disorder Scale |
| GP | General practitioner |
| HIT | High Intensity Therapist |
| IAPT | Improving Access to Psychological Therapies |
| IBS | Irritable bowel syndrome |
| ICT | Integrated Care Partnership |
| IESO | A digital IAPT service provider |
| IPT | Interpersonal psychotherapy |
| KMPT | Kent and Medway Partnership Trust |
| KPI | Key Performance Indicator |
| KLOE | Key Lines of Enquiry |
| Long−term physical health condition. | |
| LTC | A range of long−term physical health conditions such as cardiovascular disease, chronic obstructive pulmonary disease, diabetes and musculoskeletal |
| disorders. | |
| MBCT | Mindfulness−based cognitive therapy |
| MDS | Minimum Data Set |
| Medically unexplained symptoms. | |
| MUS | Persistent physical symptoms that are distressing and disabling but cannot be wholly explained by a known physical pathological cause. Examples include |
| chronic fatigue syndrome and irritable bowel syndrome. | |
| NCCMH | National Collaborating Centre for Mental Health |
| NICE | National Institute for Health and Care Excellence |
| PTSD | Post−Traumatic Stress Disorder |
| PEQ | Patient Experience Questionnaire |
| PHQ−9 | Patient Health Questionnaire for Depression |
| The descriptor corresponds with ICD−1.0 codes and captures information on | |
| the nature, severity and duration of symptoms, and their impact on | |
| P roblem descriptor |
functionality. A problem descriptor is used to support identification of appropriate NICE−recommended treatment options. It is recognised that people may have more than one mental health problem. For this reason, |
| services can enter several problem descriptors. The primary problem | |
| descriptor should reflect the treatment being delivered. | |
| PWP | Psychological wellbeing practitioner |
| Glossary | |
|---|---|
| RCT | Randomised controlled trial |
| A national standard that at least 50% of eligible referrals should move to | |
| recovery has been set for IAPT services. Aperson movesto recovery if their | |
| Recovery | symptoms were considered aclinicalcase at the start of theirtreatment(that |
| is, their symptoms exceed a defined threshold as measured by scoring tools) | |
| and not a clinical case at the end of their treatment. | |
| R eliable improvement |
A person has shown reliable improvement if there is a significant improvement in their condition following a course of treatment, measured by the difference in their first and last score. |
| Reliable | A person has 'reliably recovered' if they meet the criteria for both recovery |
| recovery | and reliable improvement. |
| Ste 2 p |
Step 2 treatments are undertaken by Psychological Wellbeing Practitioners (PWPs) and they are noted as being of low to mild/moderate levels of need. |
| Ste 3 p |
Step 3 therapists, are High Intensity Therapists (HITs) who work with higher levels of psychological need. |
| WAWU | We are with you (another IAPT service provider, previously called ThinkAction and KCA) |
| WSAS | Work and Social Adjustment Scale |